BACKGROUND: Melanopsin, a non-visual photopigment, may play a role in aberrant responses to low winter light levels in Seasonal Affective Disorder (SAD). We hypothesize that functional sequence variation in the melanopsin gene could contribute to increasing the light needed for normal functioning during winter in SAD. METHODS: Associations between alleles, genotypes, and haplotypes of melanopsin in SAD participants (n=130) were performed relative to controls with no history of psychopathology (n=90). RESULTS: SAD participants had a higher frequency of the homozygous minor genotype (T/T) for the missense variant rs2675703 (P10L) than controls, compared to the combined frequencies of C/C and C/T. Individuals with the T/T genotype were 5.6 times more likely to be in the SAD group than the control group, and all 7 (5%) of individuals with the T/T genotype at P10L were in the SAD group. LIMITATIONS: The study examined only one molecular component of the non-visual light input pathway, and recruitment methods for the comparison groups differed. CONCLUSION: These findings support the hypothesis that melanopsin variants may predispose some individuals to SAD. Characterizing the genetic basis for deficits in the non-visual light input pathway has the potential to define mechanisms underlying the pathological response to light in SAD, which may improve treatment.
BACKGROUND:Melanopsin, a non-visual photopigment, may play a role in aberrant responses to low winter light levels in Seasonal Affective Disorder (SAD). We hypothesize that functional sequence variation in the melanopsin gene could contribute to increasing the light needed for normal functioning during winter in SAD. METHODS: Associations between alleles, genotypes, and haplotypes of melanopsin in SADparticipants (n=130) were performed relative to controls with no history of psychopathology (n=90). RESULTS:SADparticipants had a higher frequency of the homozygous minor genotype (T/T) for the missense variant rs2675703 (P10L) than controls, compared to the combined frequencies of C/C and C/T. Individuals with the T/T genotype were 5.6 times more likely to be in the SAD group than the control group, and all 7 (5%) of individuals with the T/T genotype at P10L were in the SAD group. LIMITATIONS: The study examined only one molecular component of the non-visual light input pathway, and recruitment methods for the comparison groups differed. CONCLUSION: These findings support the hypothesis that melanopsin variants may predispose some individuals to SAD. Characterizing the genetic basis for deficits in the non-visual light input pathway has the potential to define mechanisms underlying the pathological response to light in SAD, which may improve treatment.
Authors: Norman F Ruby; Thomas J Brennan; Xinmin Xie; Vinh Cao; Paul Franken; H Craig Heller; Bruce F O'Hara Journal: Science Date: 2002-12-13 Impact factor: 47.728
Authors: Satchidananda Panda; Trey K Sato; Ana Maria Castrucci; Mark D Rollag; Willem J DeGrip; John B Hogenesch; Ignacio Provencio; Steve A Kay Journal: Science Date: 2002-12-13 Impact factor: 47.728
Authors: C Johansson; C Smedh; T Partonen; P Pekkarinen; T Paunio; J Ekholm; L Peltonen; D Lichtermann; J Palmgren; R Adolfsson; M Schalling Journal: Neurobiol Dis Date: 2001-04 Impact factor: 5.996
Authors: Timo Partonen; Jens Treutlein; Asude Alpman; Josef Frank; Carolina Johansson; Martin Depner; Liviu Aron; Marcella Rietschel; Stefan Wellek; Pia Soronen; Tiina Paunio; Andreas Koch; Ping Chen; Mark Lathrop; Rolf Adolfsson; Maj-Liz Persson; Siegfried Kasper; Martin Schalling; Leena Peltonen; Gunter Schumann Journal: Ann Med Date: 2007 Impact factor: 4.709
Authors: G Vandewalle; S Schwartz; D Grandjean; C Wuillaume; E Balteau; C Degueldre; M Schabus; C Phillips; A Luxen; D J Dijk; P Maquet Journal: Proc Natl Acad Sci U S A Date: 2010-10-25 Impact factor: 11.205
Authors: Stewart Thompson; Ana Recober; Timothy W Vogel; Adisa Kuburas; Jessica A Owens; Val C Sheffield; Andrew F Russo; Edwin M Stone Journal: Behav Neurosci Date: 2010-12 Impact factor: 1.912
Authors: Enda M Byrne; Uttam K Raheja; Sarah H Stephens; Andrew C Heath; Pamela A F Madden; Dipika Vaswani; Gagan V Nijjar; Kathleen A Ryan; Hassaan Youssufi; Philip R Gehrman; Alan R Shuldiner; Nicholas G Martin; Grant W Montgomery; Naomi R Wray; Elliot C Nelson; Braxton D Mitchell; Teodor T Postolache Journal: J Clin Psychiatry Date: 2015-02 Impact factor: 4.384